Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 801 results for "hodgkin"

Cheryl Rickman: Why Giving Thanks Is Life-Giving

I have this friend called Joanna. She has cancer (stage 3B non-hodgkins lymphoma) which she continues to fight with her head held high. She is, thankfully, surrounded by love from her three amazing children and wonderful husband, family and friends. Huffington Post UK, 1 day ago
[x]  

77 images for hodgkin

East Midlands Business News, 7 hours ago
Lake Forester, 22 hours ago
Lifescript.com, 1 day ago
MyNewsDesk, 1 week ago
Mount Royal University Reflector, 1 week ago
MDLinx, 1 day ago
MDLinx, 1 day ago
MDLinx, 1 day ago
MDLinx, 1 day ago
MDLinx, 1 day ago
Media Post

Still smiling despite cancer battle

The former Home And Away star, 23, was diagnosed with Hodgkin's lymphoma and revealed the shock news
 NEWS.com.au3 days ago Hey, Young People Get Lymphoma Cancers Too  Media Post1 week ago Mandy Riches: How I Used Laughtercise to Help Me Deal With Cancer  Huffington Post UK1 week ago
NPR

In The Hospital, There's No Such Thing As A Lesbian Knee

Health | Nation When my partner Cheryl was dying from respiratory complications related to treatment for Hodgkin's lymphoma, she was in so much physical distress she couldn't bear to be touched. The only contact she could stand — one of the ...
 Oregon Public Broadcasting6 days ago

Phase 1 Dose Escalation Data for Epizyme EZH2 Inhibitor EPZ-6438 (E7438) Shows Single Agent Activity in B-Cell Non-Hodgkin Lymphomas and Malignant Rhabdoid Tumor

Epizyme, Inc. ( NASDAQ: EPZM ), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced results from the Phase 1 dose ...
 Minyanville1 week ago Epizyme : Phase 1 Dose Escalation Data for Epizyme EZH2 Inhibitor EPZ-6438 (E7438) Shows Single Agent Activity in B-Cell Non-Hodgkin Lymphomas and Malignant Rhabdoid Tumor  4 Traders1 week ago
[x]  
PRWeb

Global NHL Treatment Market to Reach USD 9.2 Bln in 2020, States GBI Research in Its Report Published at MarketPublishers.com

The global non-Hodgkin lymphoma (NHL) treatment market is forecast to increase from a value of USD 5.6 billion as of 2013 to USD 9.2 billion by end-2020, posting a CAGR of just under 7.5%. A high level of unmet clinical needs and the launch of ...
 Stock Nod1 week ago ADC Market To Reach $3 Billion By 2018, Report Finds  Bioresearch Online1 week ago
[x]  
Ecancer Medicalscience

Response to new drug in patients with lymphomas and advanced solid tumors

PUBLIC RELEASE DATE: 19-Nov-2014 Barcelona, Spain: Patients with B-cell Non-Hodgkin lymphomas and advanced solid tumours have responded to a new drug that is being tested for the first time in humans in a phase I clinical trial. Preliminary ...
 EurekAlert!1 week ago Early results show response to new drug in patients with lymphomas and advanced solid tumours  Medical News Today6 days ago
[x]  

Improved Survival Shown in Early-Stage Hodgkin's Disease Patients Who Receive Radiation Therapy

ember 14, 2014 - SAN FRANCISCO, CA SAN FRANCISCO, CA--(Marketwired - September 14, 2014) - Patients with stage I and II Hodgkin's Disease who receive consolidated radiation therapy (RT) have a higher 10-year survival rate of 84 percent, compared to 76 percent ...
 Andhra News2 months ago

The Oncology Institute of Hope and Innovation Offers New Clinical Trials this Holiday Season

Below are currently opened clinical trials. If you would like more information or are interested in referring a patient to one of these trials, please contact Hilda Agajanian at (562) 869-1201. AML Celgene CC-486-AML-001: A Phase 3, Randomized, ...
 Stock Nod1 day ago
[x]  

Nordic Nanovector and Affibody collaborate on new advanced radio-immunotherapies program for Multiple Myeloma

Oslo, Norway and Solna, Sweden - Nordic Nanovector ASA and Affibody AB today announced that the companies have entered into a three-year collaborative research agreement to discover and develop new advanced radio-immunotherapies (RIT) for multiple ...
 FirstWord Pharma20 hours ago Nordic Nanovector : and Affibody Collaborate on Advanced Radio-Immunotherapies Program for Multiple Myeloma  4 Traders10 hours ago
[x]  

Cellectar Biosciences Names Vice President Of Clinical Development

MADISON, Wis., Nov. 25, 2014 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), announced the appointment of Cameron Szakacs, Ph.D., as vice president of clinical development. Dr. Szakacs brings over 18 years of leadership and experience ...
 BioSpace2 days ago Cellectar Biosciences Names Cameron Szakacs, Ph.D. Vice President of Clinical Development  Pettinga Financial Advisors2 days ago CELLECTAR BIOSCIENCES : Names Cameron Szakacs, Ph.D. Vice President of Clinical Development  4 Traders2 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less